Viewing Study NCT05307705


Ignite Creation Date: 2025-12-25 @ 3:18 AM
Ignite Modification Date: 2025-12-27 @ 10:38 PM
Study NCT ID: NCT05307705
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-19
First Post: 2022-03-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module